LMO2 and acute lymphoblastic leukemia: Targeting the expression of LMO2 to different hematopoietic cell compartments in transgenic mice, via the Sca1 promoter, revealed that LMO2 can set the identity of various cell types to give rise to an aggressive and highly disseminated T-cell ALL.